As we’ve put 2025 behind us, we did want to take time to reflect on the influences that helped direct the ongoing evolution of the compounding marketplace. At the same time, we want to offer our perspective on what trends lie ahead in 2026. Read More >
ProRx Pharma is an FDA-registered 503B facility focused on providing essential compounded sterile and non-sterile preparations. The company compounds products and formulations for medical institutions, physician offices, and 503A pharmacies, with a specialization in producing high-quality products to ensure patients have access to the medications they need during critical shortages.
This post is related to:
